Those grim days are gone when the equity market desperately needed some fresh air. Stocks are getting groovy again. Valuations are shining. As the market slowly but steadily finds its rhythm back, investors are faced with that age-old dilemma: to invest or not to invest. A lower P/E can be a temptation here. But it pays to be a little cautious. Management discretion while reporting revenue and expenses may influence reported net profit, thereby distorting P/E ratio analysis.
After recouping most of their losses over the last few weeks, Indian equity indices are once again headed for historical peaks. To some investors, this may signal soaring stock valuations, posing a dilemma when it comes to identifying investment ideas. But there is no need to panic. There are at least 26 stocks in the BSE 200 index which are trading at their 5-year low price-earnings multiples, or P/E ratios, the ubiquitous tool of investors to calibrate stock valuations. The stocks range from companies in sectors including automobiles, banking and finance, capital goods, construction and information technology to oil and gas, and power.Stocks of a majority of these companies have not been able to earn returns during the last six months, which could be one of the reasons why their P/Es are yet to surpass historical valuations. But does that make them worth a buy for the long term or is there more to it than meets the eye?
While lower P/E numbers may be a preliminary cursor or guide to relatively cheap valuations, that itself cannot be a sole trigger for investment. To help you invest, the ET Intelligence Group looked at P/E valuations closely with a sharp analysis of some of the companies in the sample. Here is our pick of companies which you could look at for investing and stocks you should steer clear of.
Price-earnings multiples of stocks offer a swift way to compare valuations. The ease of computation has made P/E ratio analysis popular among investors. P/E ratios of companies tend to move upwards in times of a sustained increase in equity indices. During the last six weeks, the Indian equity market has rebounded and so has the P/E ratios of stocks. We studied the trend in P/E ratios of companies that form part of the BSE 200 over five years ended March 2011 to identify whether there are any stocks that have historically lower valuations.
We selected the BSE 200 index since it is a fair representation of the universe of listed Indian equities by contributing over 84% to the total market capitalisation of the Bombay Stock Exchange. The 5-year time frame which we have chosen is crucial since it covers the best and the worst of times on the Indian bourses. For instance, stock valuations were scaling new peaks in 2007 until early 2008. Equities tanked across the globe in the aftermath of the global financial crisis in the subsequent months. Valuations fell steeply during the fag end of 2008.
Markets gradually recovered since the middle of 2009 with another bull run in 2010. As expected, the majority of the BSE 200 components today trade at higher valuations than in the past. Every four out five index companies command a P/E which exceeds the average annual P/E in each of the past five fiscals. This also reflects that at current market levels, valuations of most stocks are not cheap anymore.
While this is true, there are still a few stocks — 26, to be precise — in the BSE 200 that currently trade at 5-year low valuations. Their average P/Es in March 2011 were lower than the average P/Es in the last five years. But mere low valuations do not justify an investment since they may not reflect the company's future growth prospects. In some cases, P/Es could be lower since growth in the long term is expected to be sluggish either because of company-specific issues or due to concerns that impact the whole sector or the economy.
To provide more clarity, we selected 16 frequently traded stocks from our sample and analysed their past financial performance and also what lies ahead for these companies. We believe that there are 12 stocks which look attractive at current valuations, considering their prospects. Read on to find out why you should consider them and why you should avoid the rest.
What You Need to Know
Price-earnings multiple, or P/E, relates to a stock's market price to its annual net profit per share. A P/E of three indicates that the current stock price is three times its annual earnings per share. It also means that if the company maintains the current level of profits — without showing either growth or decline — then investors will take three years to make good their investment, assuming that the entire net profit is distributed in the form of a dividend.
P/E Pitfalls You Can Avoid
When a company reports a net loss, the P/E ratio becomes meaningless. In such a scenario, price-to-book or price-sales ratios may provide a better picture.
A lack of growth momentum may drive P/E valuations of a stock lower. Therefore, investors should study financia parameters and growth prospects before investing in low P/E stocks.


The growth of this South-based state run bank has been sluggish over the last two years, but over the past six months, it has streamlined its processes, and strengthened its credit appraisal system to aid advances growth.
The bank recently received a capital infusion of 370 crore from the government. The infusion will help the bank improve credit growth and maintain its net interest margin at 2.8% or above.
At a price-earning multiple of 6.6, the bank's valuation is cheap in comparison with P/Es of 8-10 for its peers. The future performance of the bank will hinge on its ability to maintain the momentum in advances and to curb bad loans.


Even though the company has reported disappointing numbers in the quarter ended December 2010 due to execution delays, the inflow of orders remains strong in the last nine months.
In addition to it, NCC recently acquired a 55% stake in the power plant, along with Gayatri projects. This is in line with its long-term strategy of getting into the power business, which is going to be a catalyst for a further upside, besides earning from regular revenue streams.
Since NCC is well-placed to reap the benefits due to a well-diversified portfolio across the infrastructure segment, investors with a 2-year horizon can take exposure.


For instance, during the trailing 12 months ended December 2010 quarter, Hero Honda's net sales grew 19.5% year-on-year to 18,132 crore while operating profit margin declined 390 basis points to 13.3%. This was much lower than Bajaj Auto's net sales which grew 51.9% during this period while operating margins grew 250 basis points to 20.6%.
Furthermore, the entire process of Honda exiting from the Indian listed joint venture Hero Honda has been perceived to be opaque. Hero Honda trades at a P/E of 17.5 times on a trailing basis. Investors can reduce their position in this stock.














With an improvement in the financial health of most state electricity boards, buying of merchant tariffs is expected to increase. The fuel cost pass through will insulate it from fuel risks. The current valuation of price to book value of three reflects all these risks.




Its outstanding order book, at the end of FY 11, was 1,64,130 crore, which is nearly four times its provisional FY 11 turnover. This gives it a reasonable revenue visibility over the next few years.
In the light of growing competition from Chinese suppliers and easier Chinese financing options, cash rich BHEL has been contemplating the launch of its own Non-Banking Finance Corporation (NBFC).
The NBFC will not only earn better returns on the current cash balance but will also help the company's equipment sales division.






The long-term growth drivers for Glenmark appear intact. A strong presence in the US, Asia, Africa and CIS, steady product launches, and a healthy pipeline of niche products are promising factors for the company. The stock is trading at a significant discount to its frontline peers.
Considering the growth prospects of the company's base business, the stock is trading at an attractive price to earnings multiple of 16. Since the growth of the company's core generics business remains promising, the current weakness in the stock offers a buying opportunity for investors scouting the mid-cap segment.







0 comments:
Post a Comment